Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
57%(4 trials)

Phase Distribution

Ph phase_1
3
38%
Ph phase_2
1
13%
Ph phase_3
4
50%

Phase Distribution

3

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
4(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (37.5%)
Phase 21 (12.5%)
Phase 34 (50.0%)

Trials by Status

completed788%
unknown113%

Recent Activity

0 active trials
Showing 5 of 8
unknownphase_3

Community Studies of Long Acting Buprenorphine (CoLAB)

NCT03809143
completedphase_3

Open-Label Treatment Extension Study

NCT02896296
completedphase_3

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

NCT02510014
completedphase_2

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects

NCT01738503
completedphase_3

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

NCT02357901
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03809143Phase 3

Community Studies of Long Acting Buprenorphine (CoLAB)

Unknown
NCT02896296Phase 3

Open-Label Treatment Extension Study

Completed
NCT02510014Phase 3

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Completed
NCT01738503Phase 2

Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects

Completed
NCT02357901Phase 3

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Completed
NCT02559973Phase 1

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

Completed
NCT03002961Phase 1

Single Ascending Dose Study of RBP-6000

Completed
NCT02765867Phase 1

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8